Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remission
- Resource Type
- Short Communication
- Authors
- Jabbour, Elias; Haddad, Fadi G.; Short, Nicholas J.; Senapati, Jayastu; Jain, Nitin; Sasaki, Koji; Jorgensen, Jeffrey; Wang, Sa A.; Alvarado, Yesid; Wang, Xuemei; DiNardo, Courtney; Masarova, Lucia; Kadia, Tapan; Garris, Rebecca S.; Ravandi, Farhad; Kantarjian, Hagop
- Source
- In Blood 1 February 2024 143(5):417-421
- Subject
- Brief Reports
Clinical Trials and Observations
Lymphoid Neoplasia
- Language
- ISSN
- 0006-4971